Adolescent Cancer Survivors & Parents: Worries & Challenges at End-of-Treatment
青少年癌症幸存者
基本信息
- 批准号:8619872
- 负责人:
- 金额:$ 7.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-28 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acute Lymphocytic LeukemiaAddressAdolescentAftercareAgeAnxietyB-Cell NonHodgkins LymphomaBehaviorBehavioralCancer SurvivorCaringChildChronic DiseaseCodeComprehensive Cancer CenterDataDatabasesDevelopmentDiagnosisEffectivenessEmotionalExtramural ActivitiesFaceGrantHealthHealth PersonnelHealthcare SystemsHodgkin DiseaseInfectionInjuryInterventionInterviewLate EffectsLeadLifeLife StyleLong-Term SurvivorsMalignant NeoplasmsMeasuresMorbidity - disease rateNon-Hodgkin&aposs LymphomaOutcomePacific NorthwestParentsParticipantPhasePilot ProjectsProgram DevelopmentProtocols documentationQuestionnairesRecruitment ActivityRiskRoleServicesSocial EnvironmentSolid NeoplasmStructureSubgroupSurvivorsTelephone InterviewsTimebasecancer therapydesignempoweredexpectationexperiencefollow-uphigh riskimprovedmortalitypeerpsychosocialpublic health relevancesurvivorshiptherapy developmenttreatment effecttreatment program
项目摘要
Project summary/abstract
Approximately 5,000 adolescents ages 14 to 18 years will be diagnosed with cancer each year in the US and
an estimated 80% will become long-term survivors. Adolescent cancer long-term survivors have some of the
highest risks for treatment-related late effects, predisposing them to cancer-related morbidity and early
mortality, as well as negative psychosocial and developmental outcomes. A particularly challenging time for
adolescent survivors and their parents is end-of-treatment. End-of-treatment means the adolescent is no
longer receiving treatment, and interactions with health care providers become much fewer and less frequent
for adolescents and parents. End-of treatment presents intense challenges for adolescents and their parents,
but a paucity of studies have described adolescent or parent's experiences at this juncture. The specific aims
of this pilot study are to: 1) Describe and compare the worries, perceived challenges, and ways of managing
these issues for adolescent cancer survivors (14 to 18 years) and their parents at end-of-treatment and follow-
up; 2) Describe the behavioral-emotional functioning of adolescents and parents' anxiety at end-of-treatment
and follow-up; and 3) Evaluate the effectiveness of the study's protocol for recruitment of adolescent-parent
dyads. Forty participants (20 adolescents, 20 parents) will be recruited from a Comprehensive Cancer Center
in the Pacific Northwest. Two subgroups will be recruited: 1) adolescents with acute lymphoblastic leukemia
and non-Hodgkin's B-cell lymphoma and their parents and 2) adolescents with solid tumors, Hodgkin's
disease, and other non-Hodgkin lymphomas and their parents. Semi-structured telephone interviews will be
conducted separately for adolescents and parents within one month of the end-of-treatment and at three and
six months. Content analysis with inductive coding will be used to analyze the interview data. Standardized
questionnaires will be used to measure adolescents' emotional-behavioral functioning and parental anxiety.
Study findings will inform the eventual development of a larger extramural grant and an adolescent-parent
intervention to improve end-of-treatment transition. This study will be the first important step in addressing the
health and developmental needs of adolescent cancer survivors and their parents after treatment.
项目摘要/摘要
在美国,大约有5,000名14至18岁的青少年将被诊断出患有癌症
估计80%将成为长期幸存者。青春期癌症长期幸存者有一些
与治疗相关的晚期作用的最高风险,使其易于癌症相关的发病率和早期
死亡率以及负面的社会心理和发展结果。一个特别具有挑战性的时间
青少年幸存者及其父母是治疗的终结。治疗结束意味着青少年是没有的
更长的接受治疗,与医疗保健提供者的互动变得越来越少了
适用于青少年和父母。治疗终结给青少年及其父母带来了巨大的挑战,
但是很少研究描述了这个关头的青少年或父母的经历。具体目标
这项试点研究是:1)描述和比较忧虑,感知到的挑战和管理方式
这些问题针对青少年癌症幸存者(14至18年)及其父母在治疗结束和跟随 -
向上; 2)描述青少年和父母在治疗时的焦虑的行为情感功能
和跟进; 3)评估研究方案招募青少年父母的有效性
二元。将从一个综合的癌症中心招募40名参与者(20名青少年,20名父母)
在西北太平洋。将招募两个亚组:1)患有急性淋巴细胞白血病的青少年
和非霍奇金的B细胞淋巴瘤及其父母以及2)患有实体瘤的青少年,霍奇金的
疾病,其他非霍奇金淋巴瘤及其父母。半结构化电话采访将是
在治疗结束后的一个月内,在三个月内分别为青少年和父母进行。
六个月。归纳编码的内容分析将用于分析访谈数据。标准化
问卷将用于衡量青少年的情感行为功能和父母的焦虑。
研究结果将为最终的较大壁外赠款和青少年父母的发展提供信息
干预以改善治疗结束过渡。这项研究将是解决问题的第一步
治疗后,青少年癌症幸存者及其父母的健康和发展需求。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amy J Walker其他文献
Amy J Walker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amy J Walker', 18)}}的其他基金
Parenting in the Face of Cancer: Non-Ill Sibling and Parent Relationships
面对癌症时的养育子女:无病兄弟姐妹和父母关系
- 批准号:
9252393 - 财政年份:2016
- 资助金额:
$ 7.87万 - 项目类别:
Adolescent Cancer Survivors & Parents: Worries & Challenges at End-of-Treatment
青少年癌症幸存者
- 批准号:
8932766 - 财政年份:2014
- 资助金额:
$ 7.87万 - 项目类别:
Sleep, Symptoms, and Quality of Life in Adolescents during Chemotherapy
青少年化疗期间的睡眠、症状和生活质量
- 批准号:
7274592 - 财政年份:2007
- 资助金额:
$ 7.87万 - 项目类别:
Sleep, Symptoms, and Quality of Life in Adolescents during Chemotherapy
青少年化疗期间的睡眠、症状和生活质量
- 批准号:
7417789 - 财政年份:2007
- 资助金额:
$ 7.87万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 7.87万 - 项目类别:
A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia
预测儿童急性白血病甲氨蝶呤神经毒性的系统流行病学方法
- 批准号:
10655716 - 财政年份:2023
- 资助金额:
$ 7.87万 - 项目类别:
Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations
定义 Ph 样 ALL 基因组重排机制以确定高危西班牙裔人群的预测标记
- 批准号:
10347835 - 财政年份:2022
- 资助金额:
$ 7.87万 - 项目类别:
Using Real Time Mobile Health Approaches to Understand and Promote Oral Chemotherapy Adherence in Adolescents and Young Adults with Leukemia
使用实时移动健康方法来了解和促进患有白血病的青少年和年轻人的口服化疗依从性
- 批准号:
10703839 - 财政年份:2022
- 资助金额:
$ 7.87万 - 项目类别:
Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations
定义 Ph 样 ALL 基因组重排机制以确定高危西班牙裔人群的预测标记
- 批准号:
10737875 - 财政年份:2022
- 资助金额:
$ 7.87万 - 项目类别: